AU2998399A - Anticancer agents - Google Patents

Anticancer agents

Info

Publication number
AU2998399A
AU2998399A AU29983/99A AU2998399A AU2998399A AU 2998399 A AU2998399 A AU 2998399A AU 29983/99 A AU29983/99 A AU 29983/99A AU 2998399 A AU2998399 A AU 2998399A AU 2998399 A AU2998399 A AU 2998399A
Authority
AU
Australia
Prior art keywords
anticancer agents
anticancer
agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU29983/99A
Inventor
Ho-Shen Lin
Michael Enrico Richett
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of AU2998399A publication Critical patent/AU2998399A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
    • C07D241/40—Benzopyrazines
    • C07D241/42—Benzopyrazines with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/498—Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
AU29983/99A 1998-04-13 1999-03-11 Anticancer agents Abandoned AU2998399A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US8155898P 1998-04-13 1998-04-13
US60081558 1998-04-13
PCT/US1999/005307 WO1999052365A1 (en) 1998-04-13 1999-03-11 Anticancer agents

Publications (1)

Publication Number Publication Date
AU2998399A true AU2998399A (en) 1999-11-01

Family

ID=22164923

Family Applications (1)

Application Number Title Priority Date Filing Date
AU29983/99A Abandoned AU2998399A (en) 1998-04-13 1999-03-11 Anticancer agents

Country Status (2)

Country Link
AU (1) AU2998399A (en)
WO (1) WO1999052365A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8802687B2 (en) 2009-02-09 2014-08-12 Georgetown University Cadherin-11 inhibitors and methods of use thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4486432A (en) * 1982-09-30 1984-12-04 Eli Lilly And Company Quinoxalinedione leukotriene release inhibitors
US4692449A (en) * 1986-06-20 1987-09-08 American Cyanamid Company Substituted quinolinediones

Also Published As

Publication number Publication date
WO1999052365A1 (en) 1999-10-21

Similar Documents

Publication Publication Date Title
AUPO721997A0 (en) Anticancer compounds
AU3485999A (en) Neo-tryptophan
AU9392998A (en) Pack-a-pillow
AU3645397A (en) Anticancer agents
AU3522399A (en) Carvedilol-galenics
AU3437799A (en) City-car
AUPP328398A0 (en) Remove-a-line
AU2656799A (en) Metal-thiols as imminomodulating agents
AU5407599A (en) Sphingolipid-desaturase
AU3253699A (en) Myxochelines
AU7446000A (en) Antitumor agents
AU8363398A (en) Capotasto
AU5757799A (en) Weed-controlling agents
AU2609599A (en) Sensor-coupling
AU2069199A (en) Codelets
AU3204999A (en) Futureball
AU1055399A (en) Rollerboard
AU3347599A (en) Aeromobile
AU9347498A (en) Imidazotriazolopyrimidines
AU5223199A (en) Bathtub-bathseat
AU2998399A (en) Anticancer agents
AU2840799A (en) 1-phosphanorbornadienes
AU9218098A (en) Exocyclic-phosphoethanolamines
AU1779099A (en) Heterocyclyl-derivatives
AU4768799A (en) Bookcover

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase